Skip to search formSkip to main contentSkip to account menu

veralipride

Known as: N-(1-allyl-2-pyrrolidinyl)methyl-2,3-dimethoxy-5-sulfamoylbenzamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1985
1985
Thirty-six menopausal women and 18 women with surgically-induced menopause were treated with a daily oral dose of 100 mg of… 
Review
1985
Review
1985
The various studies of the tolerance of veralipride (Agreal) have revealed, in general, excellent results. A mild increase in the… 
1983
1983
The effectiveness on hot flushes and clinical tolerance of veralipride were compared to those of natural estrogens in a… 
1982
1982
The value of veralipride in menopausal disorders is no longer questionable and has been documented by a number of studies. The… 
1982
1982
We studied a case of surgical menopause in a hysterical patient. Castration was followed by depression with sexual disorders… 
1982
1982
Menopausal complaints, especially hot flushes, are common occurrences. Until now, no effective treatment was available for… 
1980
1980
A preliminary open study was conducted in 20 women with menopausal sudden flushes to assess the effect of veralipride… 
1980
1980
Administration of 2 mg/kg/day of veralipride to intact female rats for 3 weeks provokes mammary gland development and, in some…